Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) beneficiaries as of Aug
The hormone signals the pancreas to release insulin, tells the stomach to slow down gastric emptying, and communicates with appetite centers in the brain to create a feeling of fullness
Pregnancy: Discontinue semaglutide or tirzepatide at least 2 months before a planned pregnancy
Saxenda, with the patient
Participation in the BALANCE Model is voluntary for drug manufacturers, state Medicaid programs, and Medicare Part D plans, but there was insufficient interest among Medicare Part D plans to move forward in 2027 Participation in BALANCE is voluntary for drug manufacturers, state Medicaid agencies, and Medicare Part D plans
Dietary measures are first implemented in individuals with significant side-effects